Pongamol
Pongamol (Lanceolatin C) is potent α-glucosidase inhibitor (IC50=103.5 μM) and has free-radical (DPPH) scavenging, antihyperglycemic, and antihyperglycemic activities[1].
Product Specifications
CAS Number
484-33-3
Product Name Alternative
Lanceolatin C
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pongamol.html
Concentration
10mM
Purity
99.81
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(CC(C1=CC=CC=C1)=O)C2=CC=C3OC=CC3=C2OC
Molecular Formula
C18H14O4
Molecular Weight
294.30
Precautions
H302, H315, H319, H335
References & Citations
[1]R Ranga Rao, et al. New furanoflavanoids, intestinal alpha-glucosidase inhibitory and free-radical (DPPH) scavenging, activity from antihyperglycemic root extract of Derris indica (Lam.) . Bioorg Med Chem. 2009 Jul 15;17 (14) :5170-5.|[2]R Ranga Rao, et al. New furanoflavanoids, intestinal alpha-glucosidase inhibitory and free-radical (DPPH) scavenging, activity from antihyperglycemic root extract of Derris indica (Lam.) . Bioorg Med Chem. 2009 Jul 15;17 (14) :5170-5.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP700138 20 µg
Eph receptor A2 (EPHA2) (NM_004431) Human Recombinant Protein
Sign In for Pricing
View Details 
LY402402 100 µg
RanBP16 (XPO7) (NM_015024) Human Over-expression Lysate
Sign In for Pricing
View Details 